Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MCL1 | Q07820 | 2/20 | 0.33 |
| ▸ | CISD1 | Q9NZ45 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | SLC16A3 | O15427 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | SLC16A1 | P53985 | 1/20 | 0.33 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.33 |
| ▸ | EGFR | P00533 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13386049 | 0.84 | EGFR (0.35) | MCL1SLC16A3ALDH1A1SLC16A1EGFR | |
| SCHEMBL13386046 | 0.84 | EGFR (0.35) | MCL1SLC16A3ALDH1A1SLC16A1EGFR | |
| SCHEMBL14629855 | 0.82 | MCL1 (0.31) | MCL1CISD1KDM4ESLC16A3ALDH1A1 | |
| SCHEMBL14629854 | 0.82 | MCL1 (0.31) | MCL1CISD1KDM4ESLC16A3ALDH1A1 | |
| SCHEMBL12051138 | 0.82 | DNM1 (0.38) | KDM4EALDH1A1CYP3A4HPGD | |
| SCHEMBL9892464 | 0.82 | DNM1 (0.38) | KDM4EALDH1A1CYP3A4HPGD | |
| SCHEMBL9892456 | 0.82 | MEN1 (0.38) | ALDH1A1 | |
| SCHEMBL15896596 | 0.77 | SLC16A3 (0.32) | SLC16A3SLC16A1EGFR | |
| SCHEMBL14629840 | 0.77 | CYP2C9 (0.37) | MCL1CISD1KDM4ESLC16A3ALDH1A1 | |
| SCHEMBL14396678 | 0.77 | CYP2C9 (0.37) | MCL1CISD1KDM4ESLC16A3ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120140161-A1 | POLYMER FILM, RETARDATION FILM, POLARIZING PLATE, LIQUID CRYSTAL DISPLAY DEVICE AND ULTRAVIOLET ABSORBER | FUJIFILM CORPORATION (JP) | 2012-06-07 | — | — | US | disclosed |
| US-20110229662-A1 | Polymer film, production method for the film, and retardation film, polarizing plate and liquid-crystal display device having the film | FUJIFILM CORPORATION (JP) | 2011-09-22 | — | — | US | disclosed |
| US-20110220843-A1 | POLYMER FILM, ULTRAVIOLET ABSORBER, MEROCYANINE COMPOUND AND PROCESS FOR PREPARING MEROCYANINE COMPOUND | FUJIFILM CORPORATION (JP) | 2011-09-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110220843-A1 | POLYMER FILM, ULTRAVIOLET ABSORBER, MEROCYANINE COMPOUND AND PROCESS FOR PREPARING MEROCYANINE COMPOUND | HAMP, CRY1, CRY2 | MCL1 2655/4885CISD1 986/4885KDM4E 790/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.